Search Results
Found 1 results
510(k) Data Aggregation
(265 days)
The ISP Safety Huber Needle Infusion Set is a safety IV administration set with a non-coring, ninety degree, right angled Huber needle, used to access a patient's surgically implanted vascular port. The ISP Safety Huber Needle Infusion Set is intended to administer fluids or to withdraw blood through the implanted vascular port. The ISP Safety Huber Needle Infusion Set facilitates safe removal of the needle within the wing to help prevent needlestick injuries when using the device for vascular port access.
The Infusion Safety Products, Inc. ISP Safety Huber Needle Infusion Set is a non-coring safety IV administration set used to access a patient's surgically implanted vascular port. The Safety Huber Needle Infusion Set is constructed with a 90°, non-coring Huber needle that is available in 19ga, 20ga and 22ga and in ½", ¾", 1″ and 1½" lengths. It is offered in various model numbers. The device is lipid resistant and contains non-latex containing products. The PVC Tubing is non-DEHP, with a flow rate of approximately 5cc per sec. max / CT rated to 300 psi. The Safety Huber Needle Infusion Set is packaged in a semi-rigid form fill and seal package with a 1059B Tyvek® lid. The sets are sterilized using a validated ethylene oxide method. The ISP Safety Huber Needle Infusion Set is intended to administer fluids or withdraw blood through the implanted vascular port (not included with the ISP Safety Huber Needle Infusion Set device is offered in the following configurations, each with various needle gauges and needle lengths: 1. Huber needle in a needle holder in a safety wing, a 7.50" length of PVC Tubing, ratchet clamp, female luer lock and vented-protector cap. Approximate Priming Volume: 0.25cc. 2. Huber needle in a needle holder in a safety wing, a 4.12″ length of PVC tubing with a ratchet clamp attached to a Y port with a non-vented cap, a second 4.12″ length of PVC off the Y port with a ratchet clamp, a female luer lock and non-vented protector cap. Approximate Priming Volume: 0.35cc. The ISP Safety Huber Needle Infusion Set facilitates safe removal of the needles by encapsulating the needle within the wing to help prevent needle stick injuries when using the device for vascular port access. The safety mechanism is engaged when the needle is removed from the access port. As the set is removed from the patient, the wing encapsulates the needle, making an audible click when secure, to prevent needle sticks to the clinician.
The provided text describes the non-clinical performance data for the ISP Safety Huber Needle Infusion Set, which is a medical device. This information is typically found in a 510(k) premarket notification to the FDA to demonstrate substantial equivalence to a predicate device.
Here's an analysis of the acceptance criteria and study information based on the provided text, structured according to your request:
Acceptance Criteria and Reported Device Performance
The device's performance is compared against internal requirements, national standards, international standards, and the predicate device (Millennium Huber Plus Safety Infusion Set, K993848).
| Acceptance Criteria / Test Description | Reported Device Performance (ISP Safety Huber Needle Infusion Set) | Predicate Device Performance (Millennium Huber Plus Safety Infusion Set) |
|---|---|---|
| Needle Insertion/Removal Force | Passed (Same forces required as predicate device: Insertion 2.20 – 2.75 lbs, Removal 2.20 – 2.50 lbs) | Insertion 2.20 – 2.65 lbs, Removal 2.20 – 2.50 lbs |
| Occlusion Testing | Passed (No occlusions at 45 psi) | No occlusions at 45 psi |
| Leak Testing | Passed (No leaks at 100 psi; also no leaks at 330 psi) | No leaks at 100 psi |
| Bonding Forces | Passed (All bonds withstood 10 lbs of force) | All bonds withstood 10 lbs of force |
| Flow Rate | Passed (Achieved 45 ml/min at 150 mmHg) | Achieved 45 ml/min at 150 mmHg |
| Simulated Clinical Study - Puncture Resistance of Safety Wings | Passed (Same as predicate: 5.9 – 6.1 lbs) | 5.5 – 6.0 lbs |
| Simulated Clinical Study - Force to Lock Safety Wings | Passed (Required less force than predicate device: 160 – 180g) | 240 – 260g |
| Simulated Clinical Study - Safety Wing Activation (Durability) | Passed (Successfully activated 200 times without failure) | Successfully activated 200 times without failure |
| Sharps Injury Protection (ISO 23908) - Activation Force of Safety Wing | Met acceptance criterion of ≤ 2.5 lbs | Not explicitly stated for predicate |
| Sharps Injury Protection (ISO 23908) - Force to Remove Needle from Port and Continue Full Activation | Met acceptance criterion of ≤ 5 lbs at each of three (3) pull speeds | Not explicitly stated for predicate |
| Sharps Injury Protection (ISO 23908) - Force to Over-ride Safety Wing Feature | Met requirement to withstand minimum of 8 lbs force | Not explicitly stated for predicate |
| Simulated Use testing | Passed (Demonstrated as safe and effective in preventing potential needle-stick injuries; may be used with one hand) | Not explicitly stated for predicate |
| Biocompatibility (ISO 10993) | Passed acceptance criteria for cytotoxicity (ISO 10993-5); irritation/intracutaneous reactivity, sensitization (ISO 10993-10); systemic toxicity and subchronic toxicity (ISO 10993-11); hemocompatibility (ISO 10993-4) including hemolysis, partial thromboplastin, complement activation assay (c3a), and complement activation assay (sc5b-9). | Not explicitly stated for predicate, but stated "equvalence in that no different questions of safety are raised." |
| Sterilization by Ethylene Oxide (ISO 11135) | Obtained SAL of 10⁻⁶; EO residuals met release acceptance criteria of <4 mg/daily dose of EO and <9mg/daily dose of ECH. | Not explicitly stated for predicate |
| Bacterial Endotoxin (ANSI/AAMI ST 72:2011) | Contained <2.0 EU/device, meeting the requirement of 20 EU/device for blood contact devices. | Not explicitly stated for predicate |
| Shelf Life Testing (ASTM F1980-07, ASTM F1929-15, ISO 11737-1, ISO 11737-2) | Sterility and seal integrity maintained to support a 2-year expiration date. | Not explicitly stated for predicate |
| Transportation Testing (ISTA 6-FedEx-A) | Packaging and devices withstood free fall drop, compression, and vibration. | Not explicitly stated for predicate |
| Conical Luer Fitting Testing (ISO 594-1) | Connectors measured within the two limit planes of the gauge with no evidence of rocking the gauge and the fitting. | Not explicitly stated for predicate |
| Lipid Resistance | All devices passed functional testing after 72 hours exposure; no evidence of cracking or crazing. | Not explicitly stated for predicate |
| Tensile Strength | All devices withstood 10 lbs of force. | Not explicitly stated for predicate |
| Core Testing (ASTM F3212) | No coring observed at 40x magnification. | Not explicitly stated for predicate |
Additional Information on the Study:
-
Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
- The document describes non-clinical performance data which are laboratory or bench tests. It doesn't specify a "test set" in the context of patient data. For the comparison tests like Needle Insertion/Removal Force, Occlusion, Leak, Bonding, Flow Rate, and Puncture Resistance, the sample sizes are not explicitly stated (e.g., "All devices tested withstood 10 lbs. of force" or "Neither the subject nor the predicate device showed occlusions").
- For the simulated clinical study and sharps injury protection testing (ISO 23908), the sample size is also not explicitly detailed beyond "subject device" and "all devices".
- Data provenance (country of origin, retrospective/prospective) is not applicable or provided given these are benchtop engineering/safety tests, not clinical studies with patient data.
-
Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
- This question is not applicable to the non-clinical performance and engineering tests described in the document. Ground truth in this context would be defined by the technical specifications and standards (e.g., ISO, ASTM, AAMI) against which the device performance is measured, rather than expert interpretation of a diagnostic outcome.
-
Adjudication method (e.g. 2+1, 3+1, none) for the test set
- Not applicable. This is not a study involving human interpretation or clinical adjudication.
-
If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- No. This is a medical device for infusing fluids/withdrawing blood and preventing needlestick injuries, not an AI-assisted diagnostic device. Therefore, an MRMC study or AI-related effectiveness is not relevant.
-
If a standalone (i.e. algorithm only without human-in-the loop performance) was done
- No. This device is a physical medical device, not an algorithm or software. The performance tests evaluate the physical properties and safety features of the device itself.
-
The type of ground truth used (expert consensus, pathology, outcomes data, etc)
- The "ground truth" for the non-clinical performance data is defined by the established technical standards and specifications (e.g., ISO 23908 for sharps injury protection, ISO 10993 for biocompatibility, specific PSI limits for leak/occlusion, force measurements for insertion/removal). The device is shown to meet these objective, measurable criteria. For comparisons to the predicate, the predicate's known performance serves as a benchmark.
-
The sample size for the training set
- Not applicable. This is not a machine learning or AI-based device, so there is no concept of a "training set".
-
How the ground truth for the training set was established
- Not applicable, as there is no training set for this device.
Ask a specific question about this device
Page 1 of 1